Contact Us
Topical Drugs Contract Development And Manufacturing Organization (CDMO) Global Market Report 2025
Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Topical Drugs Contract Development And Manufacturing Organization (CDMO) Global Market Report 2025

By Product Type (Semi-Solid Formulations, Liquid Formulations Drugs, Solid Formulations, Transdermal Products), By Service Type (Contract Development, Contract Manufacturing), By Therapeutic Area (Dermatology, Pain Management, Wound Care, Ophthalmology, Other Therapeutic Areas), By End-Use (Pharmaceutical Companies, Biopharmaceutical Companies, Other End-Uses) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview

• Topical Drugs Contract Development And Manufacturing Organization (CDMO) market size has reached to $52.9 billion in 2024

• Expected to grow to $107.61 billion in 2029 at a compound annual growth rate (CAGR) of 15.2%

• Growth Driver: Rising Skin Disease Prevalence Fuels Growth In The Topical Drugs CDMO Market

• Market Trend: Focus On State-of-the-Art Manufacturing Facilities In The Topical Drugs CDMO Market

Asia-Pacific was the largest region in 2024.

What Is Covered Under Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market?

A topical drugs contract development and manufacturing organization (CDMO) is a specialized company that provides comprehensive services for the development, formulation, and production of topical pharmaceuticals. These services include research and development, clinical trial material production, and commercial manufacturing. CDMOs help pharmaceutical companies bring topical drug products to market efficiently and compliantly.

The main product types of topical drug contract development and manufacturing organization (CDMO) are semi-solid formulations, liquid formulations, solid formulations, and transdermal products. Semi-solid formulations include creams, ointments, gels, and pastes designed for topical application. Various service types include contract development, contract manufacturing for a variety of therapeutic areas such as Dermatology, Pain Management, wound care, and ophthalmology, and others. These are used by different end-uses, which include pharmaceutical companies, biopharmaceutical companies, and others.

Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Size and growth rate 2025 to 2029: Graph

What Is The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Size 2025 And Growth Rate?

The topical drugs contract development and manufacturing organization (CDMO) market size has grown rapidly in recent years. It will grow from $52.9 billion in 2024 to $61.16 billion in 2025 at a compound annual growth rate (CAGR) of 15.6%. The growth in the historic period can be attributed to chronic disease prevalence, advanced drug delivery technologies, cost-efficient outsourcing, regulatory demands, and growth in dermatology and cosmetics.

What Is The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Growth Forecast?

The topical drugs contract development and manufacturing organization (CDMO) market size is expected to see rapid growth in the next few years. It will grow to $107.61 billion in 2029 at a compound annual growth rate (CAGR) of 15.2%. The growth in the forecast period can be attributed to personalized medicine, biologics expansion, increased R and D investments, rising skin disorder prevalence, and advanced manufacturing technologies. Major trends in the forecast period include increasing demand for innovative formulations, advancements in drug delivery technologies, rising investment in dermatological research, a surge in outsourcing by pharmaceutical companies, a focus on personalized medicine, stringent regulatory requirements necessitating specialized expertise, and the growing consumer preference for over-the-counter (OTC) skincare products.

The forecast of 15.2% growth over the next five years reflects a modest reduction of 1.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers may hamper U.S. dermatology product developers by inflating prices of specialized semi-solid manufacturing equipment and transdermal formulation expertise sourced from France and Israel, delaying topical drug production timelines. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Segmented?

1) By Product Type: Semi-Solid Formulations, Liquid Formulations Drugs, Solid Formulations, Transdermal Products

2) By Service Type: Contract Development, Contract Manufacturing

3) By Therapeutic Area: Dermatology, Pain Management, Wound Care, Ophthalmology, Other Therapeutic Areas

4) By End-Use: Pharmaceutical Companies, Biopharmaceutical Companies, Other End-Uses

Subsegments:

1) By Semi-Solid Formulations: Creams, Ointments, Gels, Pastes

2) By Liquid Formulations Drugs: Solutions, Suspensions, Emulsions, Lotions

3) By Solid Formulations: Powders, Tablets

4) By Transdermal Products: Patches

What Is Driving The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market? Rising Skin Disease Prevalence Fuels Growth In The Topical Drugs CDMO Market

The increasing prevalence of skin diseases is expected to propel the growth of the topical drugs contract development and manufacturing organization (CDMO) market going forward. Skin diseases refer to medical conditions that affect the skin, causing symptoms such as inflammation, itching, and lesions. The increasing prevalence of skin diseases can be attributed to factors such as environmental pollution, UV radiation exposure, genetic predisposition, lifestyle changes, and microbial infections. Topical drugs contract development and manufacturing organization (CDMO) helps reduce skin disease prevalence by developing and manufacturing targeted therapies that improve the management and treatment of dermatological conditions. For instance, in January 2024, according to Cancer Australia, an Australian-based cancer control agency, Australia saw a significant increase in skin melanoma cases between 2019 and 2023, with numbers rising from 15,628 to 18,257. Furthermore, in 2019, males had 9,134 cases compared to 6,494 females, while by 2023, the proportions had risen to 10,639 males and 7,618 females. Therefore, the increasing prevalence of skin diseases is driving the growth of the topical drugs contract development and manufacturing organization (CDMO) industry.

Who Are The Major Players In The Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market?

Major companies operating in the topical drugs contract development and manufacturing organization (CDMO) market are Evonik Industries AG, Eurofins Scientific SE, SGS SA, The Lubrizol Corporation, Lonza Group AG, Catalent Inc., Bora Pharmaceuticals Co. Ltd., Recipharm AB, Pierre Fabre S.A., Piramal Pharma Solutions, Cambrex Corporation, LTS Lohmann Therapie-Systeme AG, PCI Pharma Services, Famar S.A., Contract Pharmaceuticals Limited, UPM Pharmaceuticals Inc., CoreRx Inc., Halo Pharmaceutical Inc., Tapemark Company, Groupe PARIMA Inc., MedPharm Ltd., Tergus Pharma LLC, Dow Development Laboratories LLC, NextPharma Technologies Holding Limited, Tedor Pharma Inc.

What Are The Key Trends Of The Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market? Focus On State-of-the-Art Manufacturing Facilities In The Topical Drugs CDMO Market

Major companies operating in the topical drugs contract development and manufacturing organization (CDMO) market are focused on developing state-of-the-art manufacturing facilities to sustain their position in the market. A state-of-the-art manufacturing facility is a specialized production site equipped with the latest technology and advanced processes tailored for the development and manufacturing of topical pharmaceutical products. For instance, in November 2023, SOHM Inc., a US-based pharmaceutical company, launched a CDMO GMP manufacturing facility. The new Carlsbad facility will offer ample space for manufacturing topical products and SOHM's operations, with 2,500 square feet dedicated to storing finished products. Initially, IT will have a daily capacity of 500 gallons (1,892 liters) for manufacturing topicals. By the end of Q1 2024 or the start of Q2 2024, IT is expected to expand its capacity to include soft-gel suppositories.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market? Corerx Inc. Acquires Catalent Inc. To Strengthen CDMO Capabilities And Expand Market Share

In April 2024, CoreRx Inc., a US-based pharmaceutical company, acquired Societal CDMO Inc. for $130 million. The acquisition is set to enhance CoreRx into a stronger CDMO, expanding its services from early-stage development to commercial manufacturing. It will streamline operations, increase market share, and provide long-term benefits such as improved economies of scale, better R&D, and a stronger competitive position. Societal CDMO Inc. is a US-based contract development and manufacturing organization that specializes in developing and manufacturing novel drug delivery formulations.

What Is The Regional Outlook For The Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market?

Asia-Pacific was the largest region in the topical drugs contract development and manufacturing organization (CDMO) market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market?

The topical drugs contract development and manufacturing organization (CDMO) market consists of revenues earned by entities by providing services such as commercial manufacturing, research and development (R&D), regulatory support, and product lifecycle management. The market value includes the value of related goods sold by the service provider or included within the service offering. The topical drugs contract development and manufacturing organization (CDMO) market also includes sales of creams, ointments, gels, and lotions. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Topical Drugs Contract Development And Manufacturing Organization (CDMO) Industry?

The topical drugs contract development and manufacturing organization (cdmo) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the topical drugs contract development and manufacturing organization (cdmo) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $61.16 billion
Revenue Forecast In 2034 $107.61 billion
Growth Rate CAGR of 15.2% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Product Type: Semi-Solid Formulations, Liquid Formulations Drugs, Solid Formulations, Transdermal Products
2) By Service Type: Contract Development, Contract Manufacturing
3) By Therapeutic Area: Dermatology, Pain Management, Wound Care, Ophthalmology, Other Therapeutic Areas
4) By End-Use: Pharmaceutical Companies, Biopharmaceutical Companies, Other End-Uses Subsegments: 1) By Semi-Solid Formulations: Creams, Ointments, Gels, Pastes
2) By Liquid Formulations Drugs: Solutions, Suspensions, Emulsions, Lotions
3) By Solid Formulations: Powders, Tablets
4) By Transdermal Products: Patches
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Evonik Industries AG, Eurofins Scientific SE, SGS SA, The Lubrizol Corporation, Lonza Group AG, Catalent Inc., Bora Pharmaceuticals Co. Ltd., Recipharm AB, Pierre Fabre S.A., Piramal Pharma Solutions, Cambrex Corporation, LTS Lohmann Therapie-Systeme AG, PCI Pharma Services, Famar S.A., Contract Pharmaceuticals Limited, UPM Pharmaceuticals Inc., CoreRx Inc., Halo Pharmaceutical Inc., Tapemark Company, Groupe PARIMA Inc., MedPharm Ltd, Tergus Pharma LLC, Dow Development Laboratories LLC, NextPharma Technologies Holding Limited, Tedor Pharma Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Characteristics

3. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Trends And Strategies

4. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Growth Analysis And Strategic Analysis Framework

5.1. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Growth Rate Analysis

5.4. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Total Addressable Market (TAM)

6. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Segmentation

6.1. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Semi-Solid Formulations

Liquid Formulations Drugs

Solid Formulations

Transdermal Products

6.2. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Contract Development

Contract Manufacturing

6.3. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Dermatology

Pain Management

Wound Care

Ophthalmology

Other Therapeutic Areas

6.4. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pharmaceutical Companies

Biopharmaceutical Companies

Other End-Uses

6.5. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Semi-Solid Formulations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Creams

Ointments

Gels

Pastes

6.6. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Liquid Formulations Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Solutions

Suspensions

Emulsions

Lotions

6.7. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Solid Formulations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Powders

Tablets

6.8. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Transdermal Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Patches

7. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Regional And Country Analysis

7.1. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

8.1. Asia-Pacific Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

9.1. China Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview

9.2. China Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

10.1. India Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

11.1. Japan Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview

11.2. Japan Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

12.1. Australia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

13.1. Indonesia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

14.1. South Korea Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview

14.2. South Korea Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

15.1. Western Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview

15.2. Western Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

16.1. UK Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

17.1. Germany Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

18.1. France Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

19.1. Italy Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

20.1. Spain Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

21.1. Eastern Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview

21.2. Eastern Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

22.1. Russia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

23.1. North America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview

23.2. North America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

24.1. USA Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview

24.2. USA Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

25.1. Canada Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview

25.2. Canada Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

26.1. South America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview

26.2. South America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

27.1. Brazil Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

28.1. Middle East Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview

28.2. Middle East Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

29.1. Africa Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Overview

29.2. Africa Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape And Company Profiles

30.1. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Competitive Landscape

30.2. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Company Profiles

30.2.1. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

30.2.3. SGS SA Overview, Products and Services, Strategy and Financial Analysis

30.2.4. The Lubrizol Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis

31. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Other Major And Innovative Companies

31.1. Catalent Inc.

31.2. Bora Pharmaceuticals Co. Ltd.

31.3. Recipharm AB

31.4. Pierre Fabre S.A.

31.5. Piramal Pharma Solutions

31.6. Cambrex Corporation

31.7. LTS Lohmann Therapie-Systeme AG

31.8. PCI Pharma Services

31.9. Famar S.A.

31.10. Contract Pharmaceuticals Limited

31.11. UPM Pharmaceuticals Inc.

31.12. CoreRx Inc.

31.13. Halo Pharmaceutical Inc.

31.14. Tapemark Company

31.15. Groupe PARIMA Inc.

32. Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

34. Recent Developments In The Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market

35. Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market High Potential Countries, Segments and Strategies

35.1 Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Countries Offering Most New Opportunities

35.2 Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Segments Offering Most New Opportunities

35.3 Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Semi-Solid Formulations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Liquid Formulations Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Solid Formulations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Transdermal Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Evonik Industries AG Financial Performance
  • Table 80: Eurofins Scientific SE Financial Performance
  • Table 81: SGS SA Financial Performance
  • Table 82: The Lubrizol Corporation Financial Performance
  • Table 83: Lonza Group AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Semi-Solid Formulations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Liquid Formulations Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Solid Formulations, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Sub-Segmentation Of Transdermal Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Topical Drugs Contract Development And Manufacturing Organization (CDMO) Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Evonik Industries AG Financial Performance
  • Figure 80: Eurofins Scientific SE Financial Performance
  • Figure 81: SGS SA Financial Performance
  • Figure 82: The Lubrizol Corporation Financial Performance
  • Figure 83: Lonza Group AG Financial Performance

Frequently Asked Questions

A topical drugs contract development and manufacturing organization (CDMO) is a specialized company that provides comprehensive services for the development, formulation, and production of topical pharmaceuticals. These services include research and development, clinical trial material production, and commercial manufacturing. CDMOs help pharmaceutical companies bring topical drug products to market efficiently and compliantly. For further insights on this market, request a sample here

The market major growth driver - Rising Skin Disease Prevalence Fuels Growth In The Topical Drugs CDMO Market. For further insights on this market, request a sample here

The topical drugs contract development and manufacturing organization (cdmo) market size has grown rapidly in recent years. It will grow from $52.9 billion in 2024 to $61.16 billion in 2025 at a compound annual growth rate (CAGR) of 15.6%. The growth in the historic period can be attributed to chronic disease prevalence, advanced drug delivery technologies, cost-efficient outsourcing, regulatory demands, and growth in dermatology and cosmetics. The topical drugs contract development and manufacturing organization (cdmo) market size is expected to see rapid growth in the next few years. It will grow to " $107.61 billion in 2029 at a compound annual growth rate (CAGR) of 15.2%. The growth in the forecast period can be attributed to personalized medicine, biologics expansion, increased R and D investments, rising skin disorder prevalence, and advanced manufacturing technologies. Major trends in the forecast period include increasing demand for innovative formulations, advancements in drug delivery technologies, rising investment in dermatological research, a surge in outsourcing by pharmaceutical companies, a focus on personalized medicine, stringent regulatory requirements necessitating specialized expertise, and the growing consumer preference for over-the-counter (OTC) skincare products. For further insights on this market, request a sample here

The topical drugs contract development and manufacturing organization (cdmo) market covered in this report is segmented –
1) By Product Type: Semi-Solid Formulations, Liquid Formulations Drugs, Solid Formulations, Transdermal Products
2) By Service Type: Contract Development, Contract Manufacturing
3) By Therapeutic Area: Dermatology, Pain Management, Wound Care, Ophthalmology, Other Therapeutic Areas
4) By End-Use: Pharmaceutical Companies, Biopharmaceutical Companies, Other End-Uses Subsegments:
1) By Semi-Solid Formulations: Creams, Ointments, Gels, Pastes
2) By Liquid Formulations Drugs: Solutions, Suspensions, Emulsions, Lotions
3) By Solid Formulations: Powders, Tablets
4) By Transdermal Products: Patches For further insights on this market,
request a sample here

Asia-Pacific was the largest region in the topical drugs contract development and manufacturing organization (CDMO) market in 2024. The regions covered in the topical drugs contract development and manufacturing organization (CDMO) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. For further insights on this market, request a sample here.

Major companies operating in the topical drugs contract development and manufacturing organization (CDMO) market are Evonik Industries AG, Eurofins Scientific SE, SGS SA, The Lubrizol Corporation, Lonza Group AG, Catalent Inc., Bora Pharmaceuticals Co. Ltd., Recipharm AB, Pierre Fabre S.A., Piramal Pharma Solutions, Cambrex Corporation, LTS Lohmann Therapie-Systeme AG, PCI Pharma Services, Famar S.A., Contract Pharmaceuticals Limited, UPM Pharmaceuticals Inc., CoreRx Inc., Halo Pharmaceutical Inc., Tapemark Company, Groupe PARIMA Inc., MedPharm Ltd., Tergus Pharma LLC, Dow Development Laboratories LLC, NextPharma Technologies Holding Limited, Tedor Pharma Inc.. For further insights on this market, request a sample here.

Major trends in this market include Focus On State-of-the-Art Manufacturing Facilities In The Topical Drugs CDMO Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon